ABSTRACT
One neuropathological feature of schizophrenia is a diminished number of dendritic spines in the prefrontal cortex and hippocampus. The neuregulin 1 (Nrg1) system is involved in the plasticity of dendritic spines, and chronic stress decreases dendritic spine densities in the prefrontal cortex and hippocampus. Here, we aimed to assess whether Nrg1 deficiency confers vulnerability to the effects of adolescent stress on dendritic spine plasticity. We also assessed other schizophrenia-relevant neurobiological changes such as microglial cell activation, loss of parvalbumin (PV) interneurons, and induction of complement factor 4 (C4). Adolescent male wild-type (WT) and Nrg1 heterozygous mice were subjected to chronic restraint stress before their brains underwent Golgi impregnation or immunofluorescent staining of PV interneurons, microglial cells, and C4. Stress in WT mice promoted dendritic spine loss and microglial cell activation in the prefrontal cortex and the hippocampus. However, Nrg1 deficiency rendered mice resilient to stress-induced dendritic spine loss in the infralimbic cortex and the CA3 region of the hippocampus without affecting stress-induced microglial cell activation in these brain regions. Nrg1 deficiency and adolescent stress combined to trigger increased dendritic spine densities in the prelimbic cortex. In the hippocampal CA1 region, Nrg1 deficiency accentuated stress-induced dendritic spine loss. Nrg1 deficiency increased C4 protein and decreased C4 mRNA expression in the hippocampus, and the number of PV interneurons in the basolateral amygdala. This study demonstrates that Nrg1 modulates the impact of stress on the adolescent brain in a region-specific manner. It also provides first evidence of a link between Nrg1 and C4 systems in the hippocampus.
Subject(s)
Amygdala , Cerebral Cortex , Complement C4/metabolism , Dendritic Spines/pathology , Microglia/metabolism , Neuregulin-1/deficiency , Resilience, Psychological , Stress, Psychological , Amygdala/metabolism , Amygdala/pathology , Animals , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Disease Models, Animal , Interneurons/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Parvalbumins/metabolism , Random Allocation , Stress, Psychological/metabolism , Stress, Psychological/pathologyABSTRACT
Little is known about the exact genes that confer vulnerability or resilience to environmental stressors during early neurodevelopment. Partial genetic deletion of neuregulin 1 (Nrg1) moderates the neurobehavioural effects of stressors applied in adolescence and adulthood, however, no study has yet examined its impact on prenatal stress. Here we examined whether Nrg1 deficiency in mice modulated the impact of prenatal stress on various behaviours in adulthood. Male heterozygous Nrg1 mice were mated with wild-type female mice who then underwent daily restraint stress from days 13 to 19 of gestation. Surprisingly, prenatal stress had overall beneficial effects by facilitating sensorimotor gating, increasing sociability, decreasing depressive-like behaviour, and improving spatial memory in adulthood. Such benefits were not due to any increase in maternal care, as prenatal stress decreased nurturing of the offspring. Nrg1 deficiency negated the beneficial behavioural effects of prenatal stress on all measures except sociability. However, Nrg1 deficiency interacted with prenatal stress to trigger locomotor hyperactivity. Nrg1 deficiency, prenatal stress or their combination failed to alter acute stress-induced plasma corticosterone concentrations. Collectively these results demonstrate that Nrg1 deficiency moderates the effects of prenatal stress on adult behaviour, but it does so in a complex, domain-specific fashion.
Subject(s)
Behavioral Symptoms/etiology , Neuregulin-1/deficiency , Prenatal Exposure Delayed Effects/physiopathology , Stress, Psychological/physiopathology , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Behavioral Symptoms/genetics , Corticosterone/blood , Dark Adaptation/genetics , Exploratory Behavior/physiology , Female , Interpersonal Relations , Male , Maternal Behavior/physiology , Maze Learning/physiology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neuregulin-1/genetics , Pregnancy , Recognition, Psychology/physiology , Sensory Gating/genetics , Sensory Gating/physiology , Stress, Psychological/genetics , Swimming/psychologyABSTRACT
The Neuregulin-1 (Nrg1)/ErbB pathway plays multiple, critical roles in early cardiac and nervous system development and has been implicated in both heart and nerve repair processes. However, the early embryonic lethality of mouse Nrg1 mutants precludes an analysis of Nrg1's function in later cardiac development and homeostasis. In this study, we generated a novel nrg1 null allele targeting all known isoforms of nrg1 in zebrafish and examined cardiac structural and functional parameters throughout development. We found that zebrafish nrg1 mutants instead survived until young adult stages when they exhibited reduced survivorship. This coincided with structural and functional defects in the developing juvenile and young adult hearts, as demonstrated by reduced intracardiac myocardial density, cardiomyocyte cell number, swimming performance and dysregulated heartbeat. Interestingly, nrg1 mutant hearts were missing long axons on the ventricle surface by standard length (SL) 5 mm, which preceded juvenile and adult cardiac defects. Given that the autonomic nervous system normally exerts fine control of cardiac output through this nerve plexus, these data suggest that Nrg1 may play a critical role in establishing the cardiac nerve plexus such that inadequate innervation leads to deficits in cardiac maturation, function and survival.
Subject(s)
Gene Expression Regulation, Developmental , Heart/innervation , Longevity/genetics , Neuregulin-1/genetics , RNA, Messenger/genetics , Zebrafish/genetics , Alleles , Animals , Animals, Genetically Modified , Base Sequence , CRISPR-Cas Systems , Electrocardiography , Embryo, Nonmammalian , ErbB Receptors/genetics , ErbB Receptors/metabolism , Gene Editing , Heart/growth & development , Larva/growth & development , Larva/metabolism , Locomotion/physiology , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Neuregulin-1/deficiency , Neurogenesis/genetics , Organogenesis/genetics , RNA, Messenger/metabolism , Zebrafish/growth & development , Zebrafish/metabolismABSTRACT
A robust, disease-relevant phenotype is paramount to the validity of genetic mouse models, which are an important tool in understanding complex diseases. Recent evidence from genome-wide association studies suggests the genetic contribution of parents to offspring is not equivalent. Despite this, few studies to date have examined the potential impact of parent genotype (i.e. origin of mutation) on the offspring of disease-relevant genetic mouse models. To elucidate the potential impact of the sex of the mutant parent on offspring phenotype, we characterized male and female offspring of an established schizophrenia mouse model, which had been generated using two different breeding schemes, in a range of disease-relevant behaviours. We compared heterozygous type III neuregulin 1 mutant (type III Nrg1+/-) and wild type-like control (WT) offspring from mutant father x WT mother pairings with offspring from mutant mother x WT father pairings. Offspring were tested in schizophrenia-relevant paradigms including the elevated plus maze (EPM), fear conditioning (FC), prepulse inhibition (PPI), social interaction (SI), and open field (OF). We found type III Nrg1+/- males from mutant fathers, but not mutant mothers, showed deficits in contextual fear-associated memory and exhibited increased social interaction, compared to their WT littermates. Type III Nrg1+/- females across breeding colonies only exhibited a subtle change to their acoustic startle response and sensorimotor gating. These results suggest a paternal-dependent transmission of genetically induced behavioural characteristics. Though the mechanisms governing this phenomenon are unclear, our results show that parental origin of mutation can alter the behavioural phenotype of genetic mouse models. Thus, researchers should carefully consider their breeding scheme when dealing with genetic mouse models of diseases such as schizophrenia.
Subject(s)
Neuregulin-1/genetics , Schizophrenia/genetics , Schizophrenic Psychology , Animals , Anxiety , Conditioning, Psychological , Disease Models, Animal , Exploratory Behavior , Fathers , Fear , Genetic Predisposition to Disease , Heterozygote , Inheritance Patterns , Mice, Inbred C57BL , Mice, Transgenic , Mothers , Motor Activity , Neuregulin-1/deficiency , Phenotype , Sensory Gating , Sex Characteristics , Social BehaviorABSTRACT
Deficits in neurite outgrowth, possibly involving dysregulation of risk genes neuregulin-1 (NRG1) and disrupted in schizophrenia 1 (DISC1) have been implicated in psychiatric disorders including schizophrenia. Electrical stimulation using conductive polymers has been shown to stimulate neurite outgrowth of differentiating human neural stem cells. This study investigated the use of the electroactive conductive polymer polypyrrole (Ppy) to counter impaired neurite outgrowth of primary pre-frontal cortical (PFC) neurons from NRG1-knock out (NRG1-KO) and DISC1-locus impairment (DISC1-LI) mice. Whereas NRG1-KO and DISC1-LI exhibited reduced neurite length and number of neurite branches compared to wild-type controls, this was not apparent for cultures on electroactive Ppy. Additionally, the use of the Ppy substrate normalised the synaptophysin and PSD95 protein and mRNA expression whereas both are usually reduced by NRG1-KO or DISC1-LI. Our findings support the utility of Ppy mediated electrical stimulation to prevent the reduction of neurite outgrowth and related synaptic protein expression in the primary PFC neurons from NRG1-KO and DISC1-LI mice, providing proof-of-concept for treating neurodevelopmental diseases including schizophrenia.
Subject(s)
Electric Stimulation , Nerve Tissue Proteins/deficiency , Neuregulin-1/deficiency , Neuronal Outgrowth , Neurons/metabolism , Prefrontal Cortex/cytology , Prefrontal Cortex/physiology , Animals , Biomarkers , Cells, Cultured , Disks Large Homolog 4 Protein/genetics , Disks Large Homolog 4 Protein/metabolism , Fluorescent Antibody Technique , Mice , Mice, Knockout , RNA, Messenger/genetics , RNA, Messenger/metabolism , Synaptophysin/genetics , Synaptophysin/metabolismABSTRACT
The endocannabinoid system is dysregulated in schizophrenia. Mice with heterozygous deletion of neuregulin 1 (Nrg1 HET mice) provide a well-characterised animal model of schizophrenia, and display enhanced sensitivity to stress and cannabinoids during adolescence. However, no study has yet determined whether these mice have altered brain endocannabinoid concentrations. Nrg1 application to hippocampal slices decreased 2-arachidonoylglycerol (2-AG) signalling and disrupted long-term depression, a form of synaptic plasticity critical to spatial learning. Therefore we specifically aimed to examine whether Nrg1 HET mice exhibit increased 2-AG concentrations and disruption of spatial learning. As chronic stress influences brain endocannabinoids, we also sought to examine whether Nrg1 deficiency moderates adolescent stress-induced alterations in brain endocannabinoids. Adolescent Nrg1 HET and wild-type (WT) mice were submitted to chronic restraint stress and brain endocannabinoid concentrations were analysed. A separate cohort of WT and Nrg1 HET mice was also assessed for spatial learning performance in the Morris Water Maze. Partial genetic deletion of Nrg1 increased anandamide concentrations in the amygdala and decreased 2-AG concentrations in the hypothalamus. Further, Nrg1 HET mice exhibited increased 2-AG concentrations in the hippocampus and impaired spatial learning performance. Chronic adolescent stress increased anandamide concentrations in the amygdala, however, Nrg1 disruption did not influence this stress-induced change. These results demonstrate for the first time in vivo interplay between Nrg1 and endocannabinoids in the brain. Our results demonstrate that aberrant Nrg1 and endocannabinoid signalling may cooperate in the hippocampus to impair cognition, and that Nrg1 deficiency alters endocannabinoid signalling in brain stress circuitry.
Subject(s)
Brain/metabolism , Cognition Disorders/etiology , Cognition Disorders/pathology , Endocannabinoids/metabolism , Neuregulin-1/deficiency , Schizophrenia/complications , Schizophrenia/genetics , Stress, Psychological/pathology , Age Factors , Analysis of Variance , Animals , Animals, Newborn , Disease Models, Animal , Lipid Metabolism/genetics , Maze Learning/physiology , Mice , Mice, Transgenic , Neuregulin-1/genetics , Signal Transduction/drug effects , Signal Transduction/physiologyABSTRACT
Insulin resistance is closely associated with obesity and is one of the earliest symptoms of type-2 diabetes. Endothelial cells are involved in the pathogenesis of insulin resistance through their role in insulin delivery and adipose tissue angiogenesis. Here we show that Ecscr (endothelial cell surface expressed chemotaxis and apoptosis regulator; also known as ARIA), the transmembrane protein that regulates endothelial cell signalling, is highly expressed in white and brown adipose tissues, and regulates energy metabolism and glucose homeostasis by modulating endothelial cell functions. Ecscr-deficient mice fed a normal chow show improved glucose tolerance and enhanced insulin sensitivity. We demonstrate that Ecscr deletion enhances the insulin-mediated Akt/endothelial nitric oxide synthase activation in endothelial cells, which increases insulin delivery into the skeletal muscle. Ecscr deletion also protects mice on a high-fat diet from obesity and obesity-related metabolic disorders by enhancing adipose tissue angiogenesis. Conversely, targeted activation of Ecscr in endothelial cells impairs glucose tolerance and predisposes mice to diet-induced obesity. Our results suggest that the inactivation of Ecscr enhances insulin sensitivity and may represent a new therapeutic strategy for treating metabolic syndrome.
Subject(s)
Disease Susceptibility/pathology , Endothelial Cells/metabolism , Endothelial Cells/pathology , Insulin/pharmacology , Neuregulin-1/metabolism , Obesity/metabolism , Obesity/pathology , 3T3-L1 Cells , Adipose Tissue/blood supply , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , Basal Metabolism/drug effects , Diet , Endothelial Cells/drug effects , Endothelial Cells/enzymology , Enzyme Activation/drug effects , Female , Gene Deletion , Glucose/metabolism , Homeostasis/drug effects , Male , Mice , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Neovascularization, Physiologic/drug effects , Neuregulin-1/deficiency , Neuregulin-1/genetics , Nitric Oxide Synthase Type III/metabolism , Phenotype , Signal Transduction/drug effects , Thermogenesis/drug effectsABSTRACT
The protease ß-secretase 1 (Bace1) was identified through its critical role in production of amyloid-ß peptides (Aß), the major component of amyloid plaques in Alzheimer's disease. Bace1 is considered a promising target for the treatment of this pathology, but processes additional substrates, among them Neuregulin-1 (Nrg1). Our biochemical analysis indicates that Bace1 processes the Ig-containing ß1 Nrg1 (IgNrg1ß1) isoform. We find that a graded reduction in IgNrg1 signal strength in vivo results in increasingly severe deficits in formation and maturation of muscle spindles, a proprioceptive organ critical for muscle coordination. Further, we show that Bace1 is required for formation and maturation of the muscle spindle. Finally, pharmacological inhibition and conditional mutagenesis in adult animals demonstrate that Bace1 and Nrg1 are essential to sustain muscle spindles and to maintain motor coordination. Our results assign to Bace1 a role in the control of coordinated movement through its regulation of muscle spindle physiology, and implicate IgNrg1-dependent processing as a molecular mechanism.
Subject(s)
Amyloid Precursor Protein Secretases/physiology , Aspartic Acid Endopeptidases/physiology , Muscle Spindles/growth & development , Muscle Spindles/physiology , Neuregulin-1/physiology , Alzheimer Disease/metabolism , Amyloid Precursor Protein Secretases/deficiency , Amyloid Precursor Protein Secretases/genetics , Animals , Aspartic Acid Endopeptidases/deficiency , Aspartic Acid Endopeptidases/genetics , Humans , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Mice, Mutant Strains , Muscle Spindles/drug effects , Neuregulin-1/deficiency , Neuregulin-1/genetics , Neurogenesis/drug effects , Neurogenesis/physiology , Protease Inhibitors/pharmacology , Protein Isoforms/genetics , Protein Isoforms/physiology , Protein Processing, Post-Translational , Psychomotor Performance/physiology , Pyrimidines/pharmacology , Signal Transduction , Thiazines/pharmacologyABSTRACT
The incidence of anxiety, mood, substance abuse disorders and schizophrenia increases during adolescence. Epidemiological evidence confirms that exposure to stress during sensitive periods of development can create vulnerabilities that put genetically predisposed individuals at increased risk for psychiatric disorders. Neuregulin 1 (NRG1) is a frequently identified schizophrenia susceptibility gene that has also been associated with the psychotic features of bipolar disorder. Previously, we established that Type II NRG1 is expressed in the hypothalamic-pituitary-adrenal (HPA) axis neurocircuitry. We also found, using a line of Nrg1 hypomorphic rats (Nrg1(Tn)), that genetic disruption of Type II NRG1 results in altered HPA axis function and environmental reactivity. The present studies used the Nrg1(Tn) rats to test whether Type II NRG1 gene disruption and chronic stress exposure during adolescence interact to alter adult anxiety- and fear-related behaviors. Male and female Nrg1(Tn) and wild-type rats were exposed to chronic variable stress (CVS) during mid-adolescence and then tested for anxiety-like behavior, cued fear conditioning and basal corticosterone secretion in adulthood. The disruption of Type II NRG1 alone significantly impacts rat anxiety-related behavior by reversing normal sex-related differences and impairs the ability to acquire cued fear conditioning. Sex-specific interactions between genotype and adolescent stress also were identified such that CVS-treated wild-type females exhibited a slight reduction in anxiety-like behavior and basal corticosterone, while CVS-treated Nrg1(Tn) females exhibited a significant increase in cued fear extinction. These studies confirm the importance of Type II NRG1 in anxiety and fear behaviors and point to adolescence as a time when stressful experiences can shape adult behavior and HPA axis function.
Subject(s)
Anxiety/genetics , Anxiety/metabolism , Fear/physiology , Neuregulin-1/deficiency , Neuregulin-1/genetics , Adrenal Glands/physiology , Age Factors , Animals , Anxiety/psychology , Chronic Disease , Fear/psychology , Female , Hypothalamus/physiology , Male , Pituitary Gland/physiology , Rats , Rats, Inbred F344 , Rats, TransgenicABSTRACT
Neuregulin-1 (NRG1) plays a crucial role in axoglial signaling during the development of the peripheral nervous system, but its importance in adulthood after peripheral nerve injury remains unclear. We used single-neuron labeling with inducible Cre-mediated knock-out animals, which enabled visualization of a subset of adult myelinated sensory and motoneurons neurons in which Nrg1 was inducibly mutated by tamoxifen treatment. In uninjured mice, NRG1-deficient axons and the associated myelin sheath were normal, and the neuromuscular junction demonstrated normal apposition of presynaptic and postsynaptic components. After sciatic nerve crush, NRG1 ablation resulted in severe defects in remyelination: axons were either hypomyelinated or had no myelin sheath. NRG1-deficient axons were also found to regenerate at a slower rate. After nerve injury, the neuromuscular junction was reinnervated, but excess terminal sprouting was observed. Juxtacrine Neuregulin-1 signaling is therefore dispensable for maintenance of the myelin sheath in adult animals but has a key role in reparative processes after nerve injury.
Subject(s)
Aging/physiology , Axons/physiology , Myelin Sheath/physiology , Nerve Fibers, Myelinated/physiology , Nerve Regeneration/physiology , Neuregulin-1/physiology , Sciatic Neuropathy/physiopathology , Aging/genetics , Animals , Axons/metabolism , Axons/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Nerve Fibers, Myelinated/pathology , Nerve Regeneration/genetics , Neuregulin-1/deficiency , Neuregulin-1/genetics , Neuromuscular Junction/genetics , Neuromuscular Junction/metabolism , Sciatic Neuropathy/genetics , Sciatic Neuropathy/metabolismABSTRACT
Neuregulin 1 (Nrg1), a schizophrenia susceptibility gene, is involved in fundamental aspects of neurodevelopment. Mice lacking any one of the several isoforms of Nrg1 have a variety of schizophrenia-related phenotypes, including deficits in working memory and sensorimotor gating, loss of spines in pyramidal neurons in the ventral subiculum, loss of dendrites in cortical pyramidal cells, loss of parvalbumin-positive interneurons in the prefrontal cortex, and altered plasticity in corticolimbic synapses. Mice heterozygous for a disruption in exon 7 of the Nrg1 gene lack Type III (cysteine-rich-domain-containing) isoforms and have sensorimotor gating deficits that may involve changes in the activity of a circuit involving projections from the ventral hippocampus (vHPC) to medium spiny neurons in the nucleus accumbens (nACC). To explore the neural basis of these deficits, we examined electrophysiological activity in the nACC and vHPC of these mice. Under urethane anesthesia, bursts of spontaneous activity propagated from the vHPC to the nACC in both wild-type and mutant mice. However, these bursts were weaker in mutant nACC, with reduced local field potential amplitude and spiking activity. Single units in mutant nACC fired less frequently within the bursts, and more frequently outside of the bursts. Moreover, within-burst nACC spiking was less modulated by vHPC activity, as determined by phase-locking to the low-frequency oscillatory components of the bursts. These data suggest that the efficacy of vHPC input to the nACC is reduced in the Type III Nrg1 heterozygotes, supporting a role for Nrg1 in the functional profile of hippocampal-accumbens synapses.
Subject(s)
Hippocampus/metabolism , Neural Pathways/metabolism , Neuregulin-1/deficiency , Neuregulin-1/genetics , Nucleus Accumbens/metabolism , Action Potentials/genetics , Animals , Cysteine/genetics , Genetic Predisposition to Disease/genetics , Hippocampus/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , Neural Pathways/pathology , Neurons/metabolism , Neurons/pathology , Nucleus Accumbens/pathology , Protein Isoforms/genetics , Protein Structure, Tertiary/geneticsABSTRACT
After CNS injuries, axon growth inhibitors from the myelin and the scar tissue at the injury site are considered major impediments to axon regeneration. The presence of several classes of inhibitors with multiple members in each class suggests functional redundancy in growth inhibition. To test redundancy within the myelin inhibitory pathway, we analyzed raphe spinal serotonergic (5-HT) axon regeneration in mice deficient in two major myelin inhibitors, Nogo and MAG, and their common receptor NgR1 (or NgR). After a complete transection spinal cord injury, there was no significant enhancement of 5-HT axon regeneration beyond the injury site in either Nogo/MAG/NgR1 triple mutants or NgR1 single mutants. Occasional, genotype-independent traversal of 5-HT axons through GFAP-positive tissue bridges at the injury site implicates GFAP-negative lesion areas as especially inhibitory to 5-HT axons. To assess the contribution of class 3 Semaphorins that are expressed by GFAP-negative meningeal fibroblasts at the injury site, we analyzed mice deficient in PlexinA3 and PlexinA4, two key receptors for class 3 Semaphorins, with or without additional NgR1 deletion. No enhanced regeneration of 5-HT or corticospinal axons was detected in PlexinA3/PlexinA4 double mutants or PlexinA3/PlexinA4/NgR1 triple mutants through a complete transection injury. In contrast with previous reports, these data demonstrate that attenuating myelin or Semaphorin-mediated inhibition of axon growth is insufficient to promote 5-HT axon regeneration and further indicate that even attenuating both classes of inhibitory influences is insufficient to promote regeneration of injured axons through a complete transection spinal cord injury.
Subject(s)
Axons/physiology , Myelin Sheath/metabolism , Nerve Regeneration/physiology , Semaphorins/metabolism , Serotonin/metabolism , Animals , Axons/pathology , Disease Models, Animal , Female , Glial Fibrillary Acidic Protein/metabolism , Luminescent Proteins/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myelin Proteins/deficiency , Myelin Sheath/genetics , Myelin-Associated Glycoprotein , Nerve Regeneration/genetics , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neuregulin-1/deficiency , Nogo Proteins , Receptors, Cell Surface/deficiency , Semaphorins/genetics , Spinal Cord Injuries/genetics , Spinal Cord Injuries/pathologyABSTRACT
Neuregulin 1 (NRG1) signaling is critical to various aspects of neuronal development and function. Among different NRG1 isoforms, the type III isoforms of NRG1 are unique in their ability to signal via the intracellular domain after gamma-secretase-dependent intramembranous processing. However, the functional consequences of type III NRG1 signaling via its intracellular domain are mostly unknown. In this study, we have identified mutations within type III NRG1 that disrupt intramembranous proteolytic processing and abolish intracellular domain signaling. In particular, substitutions at valine 321, previously linked to schizophrenia risks, result in NRG1 proteins that fail to undergo gamma-secretase-mediated nuclear localization and transcriptional activation. Using processing-defective mutants of type III NRG1, we demonstrate that the intracellular domain signaling is specifically required for NRG1 regulation of the growth and branching of cortical dendrites but not axons. Consistent with the role of type III NRG1 signaling via the intracellular domain in the initial patterning of cortical dendrites, our findings from pharmacological and genetic studies indicate that type III NRG1 functions in dendritic development independent of ERBB kinase activity. Together, these results support the proposal that aberrant intramembranous processing and defective signaling via the intracellular domain of type III NRG1 impair a subset of NRG1 functions in cortical development and contribute to abnormal neuroconnectivity implicated in schizophrenia.
Subject(s)
Cerebral Cortex/cytology , Neuregulin-1/metabolism , Neurons/metabolism , Valine/metabolism , Alanine/genetics , Animals , Axons/metabolism , Cells, Cultured , Cerebral Cortex/embryology , DNA-Binding Proteins/metabolism , Embryo, Mammalian , ErbB Receptors/deficiency , Female , Green Fluorescent Proteins/genetics , Humans , Indoles , Leucine/genetics , Luminescent Proteins/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microtubule-Associated Proteins/metabolism , Mutation/genetics , Neuregulin-1/deficiency , Neurons/cytology , Receptor, ErbB-4 , Statistics, Nonparametric , Transfection/methods , Valine/genetics , Vesicular Glutamate Transport Protein 1/metabolismABSTRACT
Abnormalities in pain perception, especially altered warmth and heat pain sensitivity, have been reported in schizophrenia. Therefore, genes associated with schizophrenia, including neuregulin-1 (NRG1), catechol-O-methyltranferase (COMT) and disrupted-in-schizophrenia-1 (DISC1), may play a role in modulating the physiological and psychological effects of pain stimuli in such patients. Thermal pain sensitivity was assessed in NRG1, COMT and DISC1 mutant mice, and the anti-nociceptive effects of acute Delta(9)-tetrahydrocannabinol (THC) were compared in NRG1 and COMT mutants. At baseline, deletion of NRG1 and DISC1 each reduced thermal pain sensitivity, while deletion of COMT increased pain sensitivity. Neither NRG1 nor COMT deletion altered the anti-nociceptive effects of acute systemic THC (8.0mg/kg). These results indicate a differential contribution of NRG1 and DISC1 vis-à-vis COMT to the processing of thermal nociceptive stimuli and extend their phenotypic relationship to psychotic illness.
Subject(s)
Catechol O-Methyltransferase/genetics , Hyperalgesia/genetics , Nerve Tissue Proteins/genetics , Neuregulin-1/genetics , Pain Threshold/drug effects , Analgesics, Non-Narcotic/therapeutic use , Analysis of Variance , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Catechol O-Methyltransferase/deficiency , Dronabinol/therapeutic use , Female , Hyperalgesia/drug therapy , Hyperalgesia/physiopathology , Male , Mice , Mice, Knockout , Mutagenesis/genetics , Nerve Tissue Proteins/deficiency , Neuregulin-1/deficiency , Pain Measurement , Reaction Time/drug effects , Sex FactorsABSTRACT
Neuregulin-1 (NRG1) and Disrupted-in-Schizophrenia-1 (DISC1) are promising susceptibility factors for schizophrenia. Both are multifunctional proteins with roles in a variety of neurodevelopmental processes, including progenitor cell proliferation, migration, and differentiation. Here, we provide evidence linking these factors together in a single pathway, which is mediated by ErbB receptors and PI3K/Akt. We show that signaling by NRG1 and NRG2, but not NRG3, increase expression of an isoform of DISC1 in vitro. Receptors ErbB2 and ErbB3, but not ErbB4, are responsible for transducing this effect, and PI3K/Akt signaling is also required. In NRG1 knockout mice, this DISC1 isoform is selectively reduced during neurodevelopment. Furthermore, a similar decrease in DISC1 expression is seen in beta-site amyloid precursor protein cleaving enzyme-1 (BACE1) knockout mice, in which NRG1/Akt signaling is reportedly impaired. In contrast to neuronal DISC1 that was reported and characterized, expression of DISC1 in other types of cells in the brain has not been addressed. Here we demonstrate that DISC1, like NRG and ErbB proteins, is expressed in neurons, astrocytes, oligodendrocytes, microglia, and radial progenitors. These findings may connect NRG1, ErbBs, Akt, and DISC1 in a common pathway, which may regulate neurodevelopment and contribute to susceptibility to schizophrenia.
Subject(s)
Amyloid Precursor Protein Secretases/metabolism , Aspartic Acid Endopeptidases/metabolism , Nerve Tissue Proteins/metabolism , Neuregulin-1/metabolism , Amyloid Precursor Protein Secretases/deficiency , Amyloid Precursor Protein Secretases/genetics , Animals , Aspartic Acid Endopeptidases/deficiency , Aspartic Acid Endopeptidases/genetics , Astrocytes/metabolism , Brain/metabolism , Cell Line , Cells, Cultured , Humans , Mice , Mice, Knockout , Microglia/metabolism , Nerve Tissue Proteins/genetics , Neuregulin-1/deficiency , Neuregulin-1/genetics , Neurogenesis , Neurons/metabolism , Oligodendroglia/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Protein Isoforms/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Rats , Receptor, ErbB-2/metabolism , Receptor, ErbB-3/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Schizophrenia/etiology , Signal TransductionABSTRACT
Neuronal migration and axon guidance constitute fundamental processes in brain development that are generally studied independently. Although both share common mechanisms of cell biology and biochemistry, little is known about their coordinated integration in the formation of neural circuits. Here we show that the development of the thalamocortical projection, one of the most prominent tracts in the mammalian brain, depends on the early tangential migration of a population of neurons derived from the ventral telencephalon. This tangential migration contributes to the establishment of a permissive corridor that is essential for thalamocortical axon pathfinding. Our results also demonstrate that in this process two different products of the Neuregulin-1 gene, CRD-NRG1 and Ig-NRG1, mediate the guidance of thalamocortical axons. These results show that neuronal tangential migration constitutes a novel mechanism to control the timely arrangement of guidance cues required for axonal tract formation in the mammalian brain.
Subject(s)
Axons/physiology , Cell Movement , Cerebral Cortex/cytology , Neuregulin-1/metabolism , Thalamus/cytology , Animals , Biological Transport , COS Cells , Cerebral Cortex/metabolism , Chlorocebus aethiops , ErbB Receptors/deficiency , Ganglion Cysts/metabolism , Mice , Mice, Transgenic , Neuregulin-1/deficiency , Neuregulin-1/genetics , Protein Isoforms , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptor, ErbB-4 , Telencephalon/cytology , Thalamus/metabolismABSTRACT
The neuregulin-1 gene is widely expressed in the central nervous system and is associated with increased risk for schizophrenia. Using an ethologically based approach, the phenotype of neuregulin-1 heterozygous knockout mice was examined by revealing the individual elements of behaviour in the murine repertoire over the prolonged course of interaction with the environment. During initial exploration, neuregulin-1 mutants displayed a phenotype characterized by increases in locomotion and rearing free, with sex-specific alterations in sifting and grooming. Over subsequent habituation, certain initial effects endured while new phenotypic effects emerged, some of which were again sex-specific. These studies elaborate a pleiotropic role of neuregulin-1 in development, plasticity and function, including sexual dimorphism, by defining the elemental, temporal and sex-specific characteristics of the neuregulin-1 mutant ethogram.
Subject(s)
Exploratory Behavior/physiology , Habituation, Psychophysiologic/physiology , Mice, Knockout/physiology , Neuregulin-1/deficiency , Sex Characteristics , Animals , Behavior, Animal , Humans , Locomotion/genetics , Male , Mice , Mice, Inbred C57BL , Time FactorsABSTRACT
Neuregulins and their erbB receptors are essential for cardiac development and postulated to be cardioprotective in the presence of injury in the postnatal heart. We tested the hypothesis that the development of doxorubicin-induced cardiotoxicity in vivo is more severe in mice with heterozygous knockout of the neuregulin-1 gene (NRG-1(+/-)) compared with wild-type mice (WT). Three-month old NRG-1(+/-) and WT mice were injected with a single dose of doxorubicin (20 mg/kg ip). Survival was analyzed by the Kaplan-Meier approach. Left ventricular (LV) function and signaling pathways were analyzed 4 days after treatment. Fifteen days after treatment, survival was significantly lower in doxorubicin-treated NRG-1(+/-) mice (NRG-1(+/-)-Dox) compared with doxorubicin-treated WT mice (WT-Dox) (15% vs. 33%, P < 0.01). LV mass was significantly lower in NRG-1(+/-)-Dox but not in WT-Dox compared with nontreated animals. LV systolic pressure and LV midwall fractional shortening were significantly lower in NRG-1(+/-)-Dox compared with WT-Dox mice. LV protein levels of NRG-1, erbB2, and erbB4 receptors were similar in WT-Dox and NRG-1(+/-)-Dox mice. However, levels of phosphorylated erbB2, Akt, and ERK-1/2 were significantly decreased in NRG-1(+/-)-Dox compared with WT-Dox mice. A significant decrease in phosphorylated P70S6K levels was also observed in NRG-1(+/-)-Dox compared with nontreated NRG-1(+/-) mice. These results demonstrate that heterozygous knockout of the neuregulin-1 gene worsens survival and LV function in the presence of doxorubicin-induced cardiac injury in vivo. This is associated with the depression of activation of the erbB2 receptor as well as Akt, p70S6K, and ERK-1/2 pathways.